However, these stimulation protocols have some disadvantages, such as increased procedure complexity, higher cost, greater risk of ovarian hyperstimulation syndrome (OHSS), and some patients experience a premature luteinising hormone (LH) surge [2]. The gene discussed is PLOD1; the disease is ovarian hyperstimulation syndrome.